admin

The World Health Organization has upgraded COVID-19 variant EG.5 to a variant of interest, or VOI, from a variant under monitoring, or VUM, as it continues to become more prevalent around the world. The variant — which has been nicknamed Eris by some media, following the Greek-alphabet designation used for other variants — has been
0 Comments
The allure of high-potential dirt-cheap stocks often tempts those looking for the next big win. This year has seen some market sectors skyrocket while others remain in the shadows, with untapped potential. These stocks continue to elude the glaring spotlight of market hype, ensuring savvy investors a chance at undiscovered treasures. Whether it’s a major
0 Comments
When the Supreme Court struck down the constitutional protection for women’s right to have an abortion, some companies said they would subsidize travel if a worker needed to leave her state to end a pregnancy. Those announcements have resulted in a “complicated trade-off” for businesses trying to attract workers and hold onto them, according to
0 Comments
The stock market has not had an easy path so far in August, with U.S. indices under pressure. While the percentage losses are not all that bad, the constant daily declines are weighing on investor sentiment. However, it has other investors looking for the best stocks to buy in August. The S&P 500 and Nasdaq
0 Comments
Investing in growth stocks can be risky, especially for those migrating into new markets or turnaround ventures. Personally, I’ve experienced losses from such endeavors. Amid rising interest rates, caution is advised for overpriced growth stocks. Despite recent declines, their valuations remain risky. Two factors contribute to their potential downfall: further interest rate hikes and underwhelming
0 Comments
Shares of Massachusetts-based T2 Biosystems (NASDAQ:TTOO) surged another 30% this week on meme stock interest. According to financial data provider Fintel.io, retail ownership has now risen over six-fold since last month. In a sense, T2’s rapid ascent comes as no surprise. Shares of the highly shorted healthcare firm have risen 110% since the start of
0 Comments
U.S. stocks were struggling for direction Thursday afternoon, with earlier gains largely fading, following a July report showing inflationary pressures for consumers remained relatively subdued last month. What’s happening The Dow Jones Industrial Average DJIA was up 83 points, or 0.2%, to 35,208. The S&P 500 SPX rose 3 points, or 0.1%, to 4,470, after
0 Comments
In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry, and T2’s Magnetic Resonance Platform (T2MR) was potentially game-changing. Shares would quickly rise to a pre-split $23. The product, however, would prove a dud. In 2020, most of
0 Comments